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The Clinical Course of Duodenal Ulcer
Associated with Hyperparathyroidism
Melvin A. Block, M.D.*; Boy Frame, M.D.**; and Thomas A. Fox, Jr., M.D.***

In 98 patients with primary hyperparathyroidism, 15 had objective evidence of
duodenal ulcer disease. Following operative correction of the hyperparathyroidism,
improvement of duodenal ulcer disease occurred usually, but not uniformly, if unassociated with non-beta islet cell tumors. Correction of hyperparathyroidism in
patients with the Zollinger-Ellison syndrome does not significantly influence the
peptic ulcer which should be given primary aggressive surgical treatment.

Although the association is not frequent, there appears to be an increased
incidence of duodenal ulcer disease in
patients having primary hyperparathyroidism. A natural question is the influence of correction of the hyperparathyroidism and its associated hypercalcemia on the course of demonstrated
duodenal ulcer disease. It led to this
review of our experience.

symptoms which may be compatible
with duodenal ulcer disease and which
may disappear after surgical correction
of the hyperparathyroidism. However,
unless the presence of a duodenal ulcer
was confirmed by x-ray such patients
were omitted from this study. Also
omitted was one patient with laboratory evidence of hyperparathyroidism
at the time of operative treatment for
duodenal ulcer because surgical exploration of the parathyroids, to confirm
the diagnosis of hyperparathyroidism,
was not performed.
The clinical course of the 15 patients
with the association of duodenal ulcer
disease and primary hyperparathyroidism is outlined in Table I . Of the total
group, 8 were females and 7 males, 3
of the females having, in addition, nonbeta islet cell tumors of the pancreas.
As is evident from Table I , the clinical course necessitated separation of
patients with duodenal ulcer disease
and hyperparathyroidism into two ma-

Clinical Experience
Through 1969, of 98 patients for
whom the diagnosis of primary hyperparathyroidism had been confirmed, 15
also had evidence of duodenal ulcer
disease demonstrated by radiologic
study, operation, or autopsy. Patients
with primary hyperparathyroidism frequently complain of digestive tract
*Division V, Department of General Surgery.
**Division V, Department of Medicine.
***Division III, Department of General Surgery.
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Table I

CLINICAL COURSE IN 15 PATIENTS OF DUODENAL ULCER DISEASE ASSOCIATED WITH PRIMARY HYPERPARATHYROIDISM
STATUS OF ACTIVITY OF DUODENAL ULCER

NO. PTS.

AGE OF PTS.

COURSE AFTER SURGICAL CORRECTION OF HYPERPARATHYROIDISM
Ulcer
Improved

Range Ave.

Recurrence

Recurrence
Required
Operation

Duration
Follow-up
in Years

3

Ulcer active at time of operative
correction of hyperparathyroidism

38-68

44

1-11

6

Ulcer inactive at time of operative
correction of hyperparathyroidism

49-69

60

1-5

3

-n
o
X

Ulcer operation required prior to
recognition of hyperparathyroidism
Associated with non-beta islet cell
tumor of pancreas (ulcer active)

a
o

Range Ave.

Not associated with islet cell tumors
of pancreas

II.

Died of
Ulcer Prior
to Operation
on f'arathy.

69

39-53

46
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jor groups on the basis of the presence
or absence of islet cell tumors producing manifestations of the ZollingerEllison syndrome. Although the total
number of patients involved does not
permit a valid statistical analysis, the
virulence of the duodenal ulcer disease
associated with non-beta islet ceU
tumors is obvious in this experience,
and conforms with recognized characteristics of the ZoUinger-EUison syndrome. Even though in one such patient the associated hyperparathyroidism was corrected first, severe duodenal
ulcer disease continued untU total gastrectomy was accomplished. Two other
patients succumbed from complications
related to perforation of peptic ulcers
before surgical consideration could be
given to associated hyperparathyroidism.
Duodenal ulcer disease unassociated
with the Zollinger-Ellison syndrome
was less severe and usually improved
symptomatically following surgical correction of associated primary hyperparathyroidism. However, one of eight
patients in whom the ulcer appeared to
be active at the time of the parathyroid
operation required surgical correction
four years later for a recurrent symptomatic, bleeding duodenal ulcer. There
was no evidence of recurrent hyperparathyroidism in this patient. A l though active ulcer disease had been
present previously in three patients, the
ulcer was clinically quiescent at the
time of removal of a parathyroid
tumor. One other patient had undergone operative correction of a duodenal ulcer and had no further difficulty with peptic ulcer disease for the
13 years prior to removal of a para-

thyroid tumor and for the subsequent
nine years.
A single parathyroid tumor was
found in all of the patients with duodenal ulcer disease unassociated with
islet cell tumors. Abnormalities in
multiple parathyroid glands were present in the three patients with the Zollinger-EUison syndrome.
Discussion
This study conforms with previous
reports indicating a small increase in
the incidence of duodenal ulcer disease
in patients with primary hyperparathyroidism,
However, our experience
emphasizes the clinical necessity of
separating patients having concomitant
duodenal ulcer disease and primary
hyperparathyroidism into two groups
on the basis of the presence or absence
of non-beta islet cell tumors.
For patients not demonstrating features of the ZoUinger-EUison syndrome, our experience, although not
statistically firm, corroborates that of
others in indicating that correction of
primary hyperparathyroidism usually
results in the amelioration of duodenal
ulcer disease.* "-" However, the overaU experience suggests that duodenal
ulcer disease in patients with primary
hyperparathyroidism unassociated with
islet cell tumors is not particularly aggressive and probably runs a course not
gready dissimUar from that unassociated with hyperparathyroidism.
Correction of hyperparathyroidism
does not guarantee freedom from serious difficulty from a duodenal ulcer.
This was shown by one patient who
later required operation for further
complications from his ulcer. Furthermore, in three patients a previously ac23
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tive duodenal lUcer was mactive at the
time of the parathyroid operation.
Variations occur in the severity of duodenal ulcer disease in patients with
hyperparathyroidism. Not all patients
having primary hyperparathyroidism
demonstrate excessive gastric secretion, The hypercalcemia and other
effects of primary hyperparathyroidism, although aggravating factors, are
probably not major determinants in
the etiology of duodenal ulcer disease
in these patients.
Correction of hypercalcemia does
not appear to significantly alter the
course of duodenal ulcer disease in patients with non-beta islet cell tumors of
the pancreas.^^"^*^ Although hypercalcemia conceivably exaggerates duodenal
ulcer disease in these patients, other
factors are more important in producing the extreme virulence of the ulcer
in the Zollinger-Ellison syndrome. Hyperparathyroidism should be given
secondary consideration in such patients since aggressive surgical control
by total gastrectomy as early as possible is indicated. Aggravation of duodenal ulcer disease by other endocrine
lesions was not evident in this study.
Experimental studies support the
view that hypercalcemia influences gastric secretion, although it is probably
not a critical factor. Species differences
make animal studies of questionable
significance for man." Evidence indicates that in man hypercalcemia results
in an increased basal secretion of hydrochloric acid as well as an increase
in the volume of gastric juice, a decrease in pepsin secretion, and an increase in mucous secretion."'!""^*
These changes do not appear to be the
result of direct effects of parathyroid

hormone since administration of this
agent has no predictable influence on
gastric secretion.^- Hypercalcemia in
man produces elevated blood levels of
gastrin, particularly in patients with
duodenal ulcers, and this then is the
likely cause of calcium-induced increased gastric acid secretion. It appears that the influence of hypercalcemia on the secretion of gastric acid
is mediated in some manner through
the vagus nerve.^" -^ There does appear
to be a direct relationship between the
level of serum calcium and gastric secretion.These effects of hypercalcemia, however, are based on acute or
short-term studies, so that long term
results in patients with hypercalcemia
are not conclusive.Nevertheless,
basal gastric secretory studies show a
reduction following operative correction of primary hyperparathyroidism.i--a«

Duodenal ulcer disease, unassociated
with endocrine disease other than hyperparathyroidism, usually does not appear particularly serious. But, if severe, it does require therapy on the
basis of usual indications. The behavior of ulcer disease associated with hyperparathyroidism may follow one of
three general patterns:
1. Heals spontaneously, or after
gastric operation, with persistent
hyperparathyroidism.
2. Persists with temporary remissions but heals after correction
of hyperparathyroidism.
3. Persists or recurs after operative
correction of hyperparathyroidism; in such patients the coexistence of the Zollinger-Ellison
syndrome should be considered.
24
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Summary and Conclusions
1. Of 98 patients with primary hyperparathyroidism, the clinical course
of an associated duodenal ulcer present in 15 depended primarUy on the
presence or absence of co-existent nonbeta islet ceU tumors of the pancreas.
2. Although hypercalcemia may
exaggerate the virulence of duodenal
ulcer disease in patients with the Zollinger-EUison syndrome, correction of
hypercalcemia does not significantly
improve the duodenal ulcer. Operative
treatment, consisting of a total gastrectomy in nearly all instances, should be
urgently provided for such patients
prior to operative consideration for the
hyperparathyroidism.
3. Although active duodenal ulcer

disease in the absence of the ZoUingerEUison syndrome usually improves following operative correction of associated primary hyperparathyroidism, this
is not uniformly true. Hypercalcemia
appears to be only one factor, and not
always a dominant etiologic factor in
the duodenal ulcer disease which varies
in severity in these patients.
4. In patients with active duodenal
ulcer disease associated with primary
hyperparathyroidism in the absence
of the Zollinger-Ellison syndrome, the
ulcer should be treated on the basis of
its own merits with consideration given
to correction first of the hyperparathyroidism if usual surgical indications for
the ulcer do not exist.
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